Flower Mound, Texas/Flint, Michigan, USA —ProTom International, Inc. (“ProTom”) is proud to announce the commencement of installation of the synchrotron accelerator, a component of the Radiance 330TM proton therapy system under development at the McLaren Proton Therapy Center (MPTC). The MPTC is being developed on the Flint campus of the McLaren Regional Medical Center and the Great Lakes Cancer Institute by McLaren Health Care and ProTom International. Proton beam therapy technology is growing more widespread in use as a form of radiation therapy for cancer.
Flower Mound, Texas/London, UK—ProTom International, Inc. (“ProTom”) is proud to announce it has entered into an arrangement with United Kingdom-based Advanced Proton Solutions Holdings Limited (“APS”) to provide its Radiance 330 proton therapy system for the new APS facility that will be built in the City of London.
Flower Mound, Texas/Morristown, New Jersey—ProTom International is proud to announce they have entered into an exclusive arrangement with New Jersey-based Atlantic Health System to provide the proton therapy system for the facility that will be built in its North Jersey marketplace. This facility will give Atlantic Health’s physicians and patients access to the most advanced form of treatment for many types of cancer.
Vahagn comes to ProTom from Hampton University Proton Therapy Institute, where he has been a key physicist in the successful opening and operation of the proton therapy center. Vahagn, originally from Yerevan, Armenia, received a “Diploma of a Physicist” from Yerevan State University in Armenia in 1999. He received a Ph.D. degree in theoretical Nuclear and High Energy Physics from The College of William and Mary in Virginia (2004)...